Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference53 articles.
1. Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade;Barakat;Eur. J. Pharmacol.,2014
2. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials;Bornstein;Neurol. Sci.,2018
3. The many faces of CREB;Carlezon;Trends Neurosci.,2005
4. Roles of oxidative stress, apoptosis, PGC-1 alpha and mitochondrial biogenesis in cerebral ischemia;Chen;Int. J. Mol. Sci.,2011
5. Microglia and neuroprotection;Chen;J. Neurochem.,2016
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Heterogeneous treatment effects of Cerebrolysin as an early add-on to reperfusion therapy: post hoc analysis of the CEREHETIS trial;Frontiers in Pharmacology;2024-01-05
2. The CREB1 inhibitor 666-15 maintains cartilage homeostasis and mitigates osteoarthritis progression;Bone & Joint Research;2024-01-02
3. Neuroprotective effects of oxytocin against ischemic stroke in rats by blocking glutamate release and CREB-mediated DNA hypermethylation;Biomedicine & Pharmacotherapy;2023-11
4. Fucoidan (A Sulfated Polysaccharide) and Cerebroprotein in Combination Alleviate the Neuroinflammation-mediated Neural Damage and Functional Deficits in the Focal Cerebral Ischemia Model of Rat;Neuroscience;2023-08
5. The Effect of Cerebrolysin in an Animal Model of Forebrain Ischemic-Reperfusion Injury: New Insights into the Activation of the Keap1/Nrf2/Antioxidant Signaling Pathway;International Journal of Molecular Sciences;2023-07-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3